Eagle Pharmaceuticals
EGRX
#11127
Rank
A$4.9 M
Marketcap
A$0.37
Share price
0.00%
Change (1 day)
-80.60%
Change (1 year)

EPS for Eagle Pharmaceuticals (EGRX)

EPS in 2023 (TTM): A$1.75

According to Eagle Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is A$1.77. In 2022 the company made an earnings per share (EPS) of A$4.60 an increase over its 2021 EPS that were of A-$0.98.

EPS history for Eagle Pharmaceuticals from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)A$1.75-62.03%
2022A$4.60-568.18%
2021A-$0.98
2019A$1.53-52.75%
2018A$3.25-36.63%
2017A$5.13-35.09%
2016A$7.901792.86%
2015A$0.42-117.39%
2014A-$2.40

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$9.95 461.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$7.82 341.18%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
A$46.02 2,495.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$25.89 1,360.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$6.73 279.83%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$4.29 141.79%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$0.67-62.18%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel